Home - Chinese Journal of Cancer Research

2024 Impact Factor of CJCR: 6.3
Journal Citation Reports ™, Clarivate Analytics

Temporal trends, disease burden and attributable risk factors of stomach and colorectal cancers among 31 countries and territories in Western Pacific region, 2000−2021

Stomach cancer (SC) and colorectal cancer (CRC) present significant public health challenges because of their high incidence and mortality. According to the International Agency for Research on Cancer (IARC), more than 968,000 new cases and nearly 660,000 deaths of SC occurred in 2022, ranking the cancer as fifth in terms of both incidence and mortality worldwide. Among the six WHO regions, the Western Pacific region (WPR) suffered from the heaviest burdens of SC and CRC.

Global, regional, and national burden of colorectal cancer, 1990−2021: An analysis from global burden of disease study 2021

Data on the global, regional and national changes in the trends of colorectal cancer (CRC) are analyzed to understand the trends in its burden, in order to assist policymakers in allocating healthcare resources and developing prevention and control strategies. Referring to the latest data from the GBD 2021, this study quantifies the impact of different factors on the global, regional, and national burden of disease associated with CRC, and focuses on the differences in the burden of CRC across different SDI regions as well as across different age groups. This study was conducted to rationally allocate medical resources and optimize preventive strategies based on the analysis of the results.

Artificial intelligence efficiently predicts gastric lesions, Helicobacter pylori infection and lymph node metastasis upon endoscopic images

Artificial intelligence has been widely applied in analysis of medical images, including computed tomography images, endoscopic images, histological images, and organoids images. In the current research, the performance of 14 convolutional neural network models was explored for classification and prediction of endoscopic images from human stomach. The purpose is to improve diagnostic accuracy and working efficiency. By training and comparison, EfficientNetB7 revealed the best performance on two-category of gastric cancer and benign lesions, gastric ulcer and ulcerated cancer, as well as early gastric cancer and non-gastric cancer. The EfficientNetB7 was also suitable for predicting the infection of Helicobacter pylori (Hp) and non-Hp infection (noHp). Notable, the InceptionV3 model was capable of predicting perigastric lymph nodes metastasis from endoscopic images.

IMpower210: A phase III study of second-line atezolizumab vs. docetaxel in East Asian patients with non-small cell lung cancer

Non-small cell lung cancer (NSCLC) accounts for more than 80% of all lung cancers, with most patients presenting with advanced or metastatic disease. Lung cancer incidence is particularly high among Asians, who constitute approximately 50% of the global cases. This study reports the results from the phase III IMpower210 study, which compared the efficacy and safety of atezolizumab monotherapy with those of docetaxel in East Asian patients with advanced or metastatic NSCLC who had experienced disease progression with platinum-based chemotherapy. IMpower210 did not meet its primary efficacy endpoint of OS in the ITT EGFR-WT or overall ITT populations. Atezolizumab was comparatively more tolerable than docetaxel, with a lower incidence of grade 3/4 TRAEs.

Plant-based dietary patterns and risk of esophageal cancer: A prospective cohort study spanning 17 years

Plant-based diets have multiple health benefits for cancers; however, little is known about the association between plant-based dietary patterns and esophageal cancer (EC). This study presents an investigation of the prospective associations among three predefined indices of plant-based dietary patterns and the risk of EC. It performed endoscopic screening for 15,709 participants aged 40−69 years from two high-risk areas of China from January 2005 to December 2009 and followed the cohort until December 31, 2022. This study proves that a healthy plant-based dietary pattern was associated with a reduced risk of EC. Emphasizing the healthiness and quality of plant-based diets may be important for preventing the development of EC.

National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)

National Health Commission of the People’s Republic of China; Society of Oncology, Chinese Medical Association

‹ ›

Vol 37, No 4 (Aug 2025)

Special Issue on Advances in Hematopoietic Stem Cell Transplantation for High-risk Hematologic Malignancies (I)

Preface

Preface to Special Issue: Advances in hematopoietic stem cell transplantation for high-risk hematologic malignancies

Xiaojun Huang

Pages: 487-489 HTML

Review Article

Strategic innovations: Tackling challenges of immunotherapy in acute myeloid leukemia

Haolong Lin, Tao Wang, Jia Wei

Pages: 490-504 HTML

Bridging transplantation and immunotherapy: Clinical promise of autologous stem cell transplantation with chimeric antigen receptor T-cell therapy

Yixin Yan, Zigang Dai, Dengju Li, Xia Mao, Liang Huang

Pages: 505-520 HTML

Original Article

Impact of clinical characteristics and genetic profiles on outcomes of allogeneic stem cell transplantation with sorafenib maintenance in FLT3-ITD acute myeloid leukemia patients: A multi-center, retrospective study

Yeqian Zhao, Chuanhe Jiang, Yi Luo, Guifang Ouyang, Lieguang Chen, Jian Yu, Yamin Tan, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Yishan Ye, Luxin Yang, Congxiao Zhang, Jimin Shi, He Huang, Xiaoxia Hu, Yanmin Zhao

Pages: 521-533 HTML

Prognostic value of post-transplantation measurable residual disease in patients with myelodysplastic syndrome: A prospective cohort study

Yuewen Wang, Lanping Xu, Yu Wang, Xiaohui Zhang, Kaiyan Liu, Yuanyuan Zhang, Chenhua Yan, Huan Chen, Yuhong Chen, Wei Han, Fengrong Wang, Jingzhi Wang, Xiaojun Huang, Yingjun Chang

Pages: 534-546 HTML

Commentary

Allogeneic hematopoietic cell transplantation in vulnerable populations: Advances and perspectives

Yi Fan, Jia Chen

Pages: 547-550 HTML

Homoharringtonine combined with venetoclax and azacitidine: An effective and safe regimen for patients with refractory/relapsed acute myeloid leukemia

Yiling Ye, Qifa Liu, Hua Jin

Pages: 551-553 HTML

Correspondence

Outcomes of adult patients with B-cell acute lymphoblastic leukemia with or without blinatumomab as bridging therapy prior to allogeneic hematopoietic stem cell transplantation

Jiayu Huang, Yi Xia, Yuhang Cheng, Bingyang Shi, Yilei Ma, Ze Tian, Luxiang Wang, Chuanhe Jiang, Haiyang Lu, Weijie Cao, Yang Cao, Xiaodong Mo, Xiaoxia Hu

Pages: 554-557 HTML

Original Article

A comparative transcriptomic analysis at single-cell resolution reveals acral melanoma features distinct from cutaneous melanoma

Hongyue Zhao, Jie Tian, Hang Li, Binbin Lai

Pages: 558-574 HTML

Association of lifestyle factors with breast cancer incidence: An overview of systematic reviews

Md Sohel Rana, Md Mijanur Rahman, Jannah Baker, Nehmat Houssami, Xue Qin Yu, M Luke Marinovich

Pages: 575-591 HTML

Long-term adherence to gastric cancer screening in South Korea: A 10-year follow-up study

Dong Jun Kim, Nan-He Yoon, Seongju Kim, Horim A Hwang, Jae Kwan Jun, Mina Suh, Sunhwa Lee, Seo Yoon Lee, Hooyeon Lee

Pages: 592-602 HTML

SMOC2^high myofibroblastic cancer-associated fibroblast drives primary cilia-associated tumor microenvironment remodeling and poor prognosis in gastric cancer

Qiqi Xu, Changjiang Yang, Jingyuan Ning, Yunze Niu, Xuesong Zhao, Long Zhao, Caihong Wang, Shan Wang, Yingjiang Ye, Zhanlong Shen

Pages: 603-623 HTML

Machine learning-based prediction model for postoperative complications in gastric and colorectal cancer: A prospective nationwide multi-center study

Jun Lu, Zhouqiao Wu, Jie Chen, Changqing Jing, Jiang Yu, Zhengrong Li, Jian Zhang, Lu Zang, Hankun Hao, Chaohui Zheng, Yong Li, Lin Fan, Hua Huang, Pin Liang, Bin Wu, Jiaming Zhu, Zhaojian Niu, Linghua Zhu, Wu Song, Jun You, Su Yan, Ziyu Li, Fenglin Liu, on behalf of the PACAGE study group

Pages: 624-638 HTML

Burden of pancreatic cancer among the Western Pacific Region and association with human resources for health from 1990 to 2021: Results from the Global Burden of Disease Study 2021

Feilong Ning, Liwei Ren, Shuo Liu, Zhiping Yang, Xiaoliang Gao, Daiming Fan

Pages: 639-656 HTML

Editorial

Updates of CSCO guidelines for colorectal cancer version 2025

Demin Lu, Caixia Dong, Kailai Wang, Chenyang Ye, Liubo Chen, Ying Yuan, Hanguang Hu

Pages: 297-302 HTML

CSCO Guidelines

CSCO guidelines for colorectal cancer version 2024: Updates and discussions

Liubo Chen, Hanguang Hu, Ying Yuan, Shanshan Weng

Pages: 233-239 HTML

CSCO guidelines for colorectal cancer version 2023: Updates and insights

Mi Mi, Shanshan Weng, Ziheng Xu, Hanguang Hu, Yi Wang, Ying Yuan

Pages: 233-238 HTML

CSCO guidelines for colorectal cancer version 2022: Updates and discussions

Zhijun Yuan, Shanshan Weng, Chenyang Ye, Hanguang Hu, Suzhan Zhang, Ying Yuan

Pages: 67-70 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)

Jun Zhu, Jun Ma, Union for China Lymphoma Investigators of Chinese Society of Clinical Oncology

Pages: 289-301 HTML

Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020

Caixia Dong, Yuwei Ding, Shanshan Weng, Guichao Li, Yanqing Huang, Hanguang Hu, Zhen Zhang, Suzhan Zhang, Ying Yuan

Pages: 302-307 HTML

Updates in version 2020 of CSCO guidelines for colorectal cancer from version 2019

Shanshan Weng, Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang

Pages: 403-407 HTML

Updates in version 2019 of CSCO guidelines for colorectal cancer from version 2018

Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang

Pages: 423-425 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer working group

Pages: 84-98 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer working group

Pages: 99-116 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer working group

Pages: 117-134 HTML

NHCPRC Guidelines

National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)

National Health Commission of the People’s Republic of China; Society of Oncology, Chinese Medical Association

Pages: 197-232 HTML